SCHEMBL23297609

SCHEMBL23297609

COc1ccc(-c2nc(Cn3c(Cl)nc4c3c(=O)n(C)c(=O)n4C)cs2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.54
▸ ADORA1 P30542 3/20 0.54
▸ MAOB P27338 2/20 0.54
▸ HTT P42858 1/20 0.54
▸ ALDH1A1 P00352 5/20 0.53
▸ POLB P06746 1/20 0.53
▸ MAPT P10636 4/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ MAPK1 P28482 2/20 0.51
▸ TDP1 Q9NUW8 2/20 0.51
▸ PCSK9 Q8NBP7 1/20 0.50
▸ THRB P10828 1/20 0.50
▸ HPGD P15428 2/20 0.49
▸ USP2 O75604 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ HIF1A Q16665 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23297612 0.90 MAOB (0.66) ADORA2AADORA1MAOBHTTALDH1A1
SCHEMBL23297620 0.89 HTT (0.57) ADORA2AADORA1MAOBHTTALDH1A1
SCHEMBL23297783 0.89 ADORA2A (0.55) ADORA2AADORA1MAOBHTTALDH1A1
SCHEMBL23297637 0.88 HTT (0.56) ADORA2AADORA1MAOBHTTALDH1A1
SCHEMBL23297598 0.88 HTT (0.56) ADORA2AADORA1MAOBHTTMAPT
SCHEMBL23297564 0.88 HTT (0.58) ADORA2AADORA1MAOBHTTALDH1A1
SCHEMBL23297803 0.88 KDM4E (0.51) ADORA2AADORA1MAOBHTTALDH1A1
SCHEMBL23297748 0.87 HTT (0.55) ADORA2AADORA1MAOBHTTALDH1A1
SCHEMBL23297630 0.87 ADORA2A (0.54) ADORA2AADORA1MAOBHTTALDH1A1
SCHEMBL23297676 0.87 SMN1; SMN2 (0.48) ADORA2AADORA1MAOBHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210128566-A1 NOVEL FUNCTIONALIZED PURINE-2,6-DIONES AND THEIR USE IN MEDICINE THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING (SE) 2021-05-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210128566-A1 NOVEL FUNCTIONALIZED PURINE-2,6-DIONES AND THEIR USE IN MEDICINE ADORA2A, HPRT1, PNP ADORA2A 1/4885ADORA1 7/4885MAOB 970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback